amiodarone has been researched along with Diabetes Mellitus, Type 2 in 9 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In patients with untreated amiodarone-induced hypothyroidism, but not in the other groups of patients, metformin reduced serum levels of thyrotropin and this effect correlated weakly with its action on insulin sensitivity." | 7.83 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. ( Gilowska, M; Krysiak, R; Okopień, B; Szkróbka, W, 2016) |
| "To evaluate whether concomitant use of amiodarone and sulfonylureas is associated with an increased risk of serious hypoglycemia." | 3.96 | Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study. ( Huang, YL; Lai, JH; Liou, JT; Lu, CH; Wang, MT; Wu, CC, 2020) |
| " These cutaneous lesions had appeared less than 2 months after initiation of amiodarone for supra-ventricular arrhythmia." | 3.85 | [Amiodarone-induced immune complex cutaneous vasculitis]. ( Fardet, L; Lebrun-Vignes, B; Ndiaye, M; Ortonne, N, 2017) |
| " In patients with untreated amiodarone-induced hypothyroidism, but not in the other groups of patients, metformin reduced serum levels of thyrotropin and this effect correlated weakly with its action on insulin sensitivity." | 3.83 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. ( Gilowska, M; Krysiak, R; Okopień, B; Szkróbka, W, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ceccarelli, SM | 1 |
| Chomienne, O | 1 |
| Gubler, M | 1 |
| Arduini, A | 1 |
| Lai, JH | 1 |
| Wang, MT | 1 |
| Wu, CC | 1 |
| Huang, YL | 1 |
| Lu, CH | 1 |
| Liou, JT | 1 |
| Torimitsu, T | 1 |
| Yoshida, T | 1 |
| Nishi, S | 1 |
| Itoh, H | 1 |
| Oya, M | 1 |
| Ndiaye, M | 1 |
| Lebrun-Vignes, B | 1 |
| Ortonne, N | 1 |
| Fardet, L | 1 |
| Spina, R | 1 |
| Granger, E | 1 |
| Walker, B | 1 |
| Subbiah, RN | 1 |
| Krysiak, R | 1 |
| Gilowska, M | 1 |
| Szkróbka, W | 1 |
| Okopień, B | 1 |
| Gómez, JJ | 1 |
| Pomar, MD | 1 |
| Casariego, AV | 1 |
| Rodríguez, IC | 1 |
| Minhaj, MM | 1 |
| Zvara, DA | 1 |
| Nayyar, P | 1 |
| Maslow, A | 1 |
| Iervasi, G | 1 |
| Clerico, A | 1 |
| Bonini, R | 1 |
| Nannipieri, M | 1 |
| Manfredi, C | 1 |
| Sabatino, L | 1 |
| Biagini, A | 1 |
| Donato, L | 1 |
1 trial available for amiodarone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fib | 1998 |
8 other studies available for amiodarone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; E | 2011 |
Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study.
Topics: Aged; Amiodarone; Case-Control Studies; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, | 2020 |
Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis.
Topics: Alstrom Syndrome; Amiodarone; Cardiomyopathy, Dilated; Diabetes Mellitus, Type 2; Female; Humans; Ki | 2022 |
[Amiodarone-induced immune complex cutaneous vasculitis].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Back; Diabetes Mellitus, Type 2; Humans; H | 2017 |
Ventricular tachycardia in hypertrophic cardiomyopathy with apical aneurysm successfully treated with left ventricular aneurysmectomy and cryoablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cryosurgery; Diabetes Mellitus, Ty | 2013 |
The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Diabetes Mellitus, Type 2; Female; Humans; Hypothalamo-Hypophyseal System; Hypothy | 2016 |
[Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetes Mellitus, Type 2; Feedback, Physio | 2009 |
Case 1-2007 morbidly obese patient undergoing cardiac surgery.
Topics: Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterizatio | 2007 |